This week’s EU health policy developments range from workforce pressures and medicine shortages to rare disease research, PFAS monitoring, and crisis preparedness. Key issues include newborn screening disparities, mental health, and data ethics in digital health and AI regulation.
This week’s EU health and governance developments range from healthcare access and ME/CFS research to glyphosate safety, burnout prevention, and humanitarian issues in Gaza. The Commission’s replies highlight growing focus on patient rights, vaccine safety, disability inclusion, and transparency in EU governance.
